Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, is ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Nirogacestat (Ogsiveo; Springworks Therapeutics) is a therapy used to treat desmoid tumors, rare but aggressive growths that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
New Drug Application (NDA) supported by positive Phase 3 RINGSIDE results, including significant improvement in progression-free survival vs. placebo (hazard ratio = 0.16, p<0.0001) Trial also met all ...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the submission of a New Drug Application (NDA ...
A blood test that detects tumor DNA circulating in the bloodstream may help select the most effective treatment options for ...
Meningiomas are the most common brain cancers arising from the protective soft tissue cover of the brain called the meninges.
Quarterly results marked by 104% revenue growth and improved operating performance –– Company issues full-year 2026 revenue guidance –– ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results